Cumulative anticholinergic exposure and white matter hyperintensity burden in community‐dwelling older adults
Journal of the American Geriatrics Society · 2025
DOI: 10.1111/jgs.19325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, 2025. Verfasst von Kevin H Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Cholinergic Antagonists, White Matter, Dementia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institute on Aging.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Anticholinergic exposure is associated with dementia risk; however, the mechanisms for this association remain unclear. The objective of this study was to examine the association between anticholinergic exposure and white matter hyperintensity (WMH) burden.
Methods
This was a retrospective analysis of data from the Adult Changes in Thought (ACT) study, a prospective cohort study among adults aged ≥65 years on dementia risk factors. We used data collected through March 2020 for this analysis. The sample included ACT participants who were referred for and had a clinical magnetic resonance imaging (MRI) scan and ≥10 years of continuous healthcare enrollment prior to the scan. Our primary exposure was total standardized daily dose (TSDD) of anticholinergics. Outcomes included three semi‐quantitative ratings of WMH volume. We used separate linear regression models for each outcome to estimate and compare covariate‐adjusted mean values of WMH ratings in each exposure group.
Results
Of the 1043 individuals included in the analyses, 28% had no use, 33% had 1–90 TSDD, 15% had 91–365 TSDD, 7% had 366–1095 TSDD, and 17% had ≥1096 TSDD. The mean age was 81 years, most were female (58%) and White race (88%). Compared to those with no use, the ≥1096 TSDD group had a higher (worse) adjusted mean [95% confidence intervals] Fazekas (4.0 [3.8, 4.2] vs. 3.4 [3.2, 3.5]; p :
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Washington, Seattle, Washington, USA.
- Kaiser Permanente Washington Research Institute, Seattle, Washington, USA.
- Department of Medicine, University of Washington, Seattle, Washington, USA.
- Department of Radiology, University of Washington, Seattle, Washington, USA.
- University of California, San Francisco, San Francisco, California, USA.
- Department of Neurological Surgery, University of Washington, Seattle, Washington, USA.
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- National Institute on Aging
Zitieren
APA
Li, K. H., Krakauer, C., Nelson, J. C., Crane, P. K., Andre, J. B., Curl, P. K., Yuh, E., Mossa-Basha, M., Ralston, J. D., Mac Donald, C. L., & Gray, S. L. (2025). Cumulative anticholinergic exposure and white matter hyperintensity burden in community‐dwelling older adults. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.19325
Vancouver
Li KH, Krakauer C, Nelson JC, Crane PK, Andre JB, Curl PK, et al. Cumulative anticholinergic exposure and white matter hyperintensity burden in community‐dwelling older adults. Journal of the American Geriatrics Society. 2025. doi:10.1111/jgs.19325
BibTeX
@article{Li2025,
author = {Li, Kevin H and Krakauer, Chloe and Nelson, Jennifer C and Crane, Paul K and Andre, Jalal B and Curl, Patti K and Yuh, Esther and Mossa-Basha, Mahmud and Ralston, James D and Mac Donald, Christine L and Gray, Shelly L},
title = {Cumulative anticholinergic exposure and white matter hyperintensity burden in community‐dwelling older adults},
journal = {Journal of the American Geriatrics Society},
year = {2025},
doi = {10.1111/jgs.19325}
}
EUVIMED